FARALLON CAPITAL MANAGEMENT LLC
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 909661
SAN FRANCISCO, CA
Position in CRNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$302,839,719
-$19,895,992 QoQ
Shares Held
8,338,098
+20.3% QoQ
Ownership
7.91%
of shares outstanding
% of Portfolio
2.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FARALLON CAPITAL MANAGEMENT LLC holds $5,160,870,541 across 65 Biotechnology names. CRNX ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
13,604,796 | $1,323,066,411 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
9,365,463 | $695,479,282 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
6,348,906 | $669,174,692 | |
| 4 | EXEL |
Exelixis, Inc.
|
13,111,010 | $562,331,218 | |
| 5 | CRNX |
Crinetics Pharmaceuticals, Inc.
This page
|
8,338,098 | $302,839,719 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
9,675,000 | $267,997,500 | |
| 7 | BEAM |
Beam Therapeutics Inc.
|
10,134,696 | $241,509,805 | |
| 8 | AGIO |
Agios Pharmaceuticals, Inc.
|
5,684,000 | $192,289,720 |
All Filings in CRNX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $302,839,719 | 8,338,098 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $322,735,711 | 6,933,098 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $240,324,581 | 5,770,098 | Shares | Other | 2026-02-17 | |
| 2025-06-30 | $133,621,778 | 4,646,098 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $154,454,986 | 4,605,098 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $208,359,760 | 4,075,098 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $59,378,200 | 1,162,000 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $22,260,630 | 497,000 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $234,050 | 5,000 | Shares | Other | 2024-05-24 | |
| 2023-12-31 | $4,372,924 | 122,904 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $10,763,024 | 361,904 | Shares | Other | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||